Skip to content

Cerebral Oximetry and Anesthetic Technique

Evaluation of the Effects of Spinal Versus General Anesthesia on Transcranial Cerebral Oxygen Saturation in Geriatric Patients Undergoing Total Hip Arthroplasty

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03349658
Enrollment
82
Registered
2017-11-21
Start date
2017-01-31
Completion date
2017-08-31
Last updated
2017-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disorder of Hip Joint

Keywords

total hip arthroplasty, cerebral oxygen saturation, general anesthesia, spinal anesthesia

Brief summary

The purpose of the study is to compare the effects of spinal and general anesthesia on transcranial regional cerebral oxygen saturation in geriatric patients undergoing total hip arthroplasty.

Detailed description

Geriatric patients who received anesthesia undergoing total hip arthroplasty were randomized by means of a computer-generated randomization order into two groups; general anesthesia group (Group 1) and spinal anesthesia group (Group 2). Before and after induction of the general or spinal anesthesia, patients were monitorized with near infrared spectroscopy for regional cerebral oxygen saturation. Findings were compared statistically.

Interventions

OTHERgeneral anesthesia

effect of general anesthesia on transcranial regional cerebral oxygen saturation

OTHERspinal anesthesia

effect of spinal anesthesia on transcranial regional cerebral oxygen saturation

Sponsors

Antalya Training and Research Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
65 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* patients who undergo elective total hip arthroplasty * American Society of Anesthesiologists class 1 to 3 * Ability to consent

Exclusion criteria

* Pulmonary disease * History of allergic reaction to local anaesthetics * Peripheral neuropathy * Neurologic disease * Coagulation disorders

Design outcomes

Primary

MeasureTime frameDescription
Change in transcranial regional cerebral oxygenation (rSO2)60 minutesAssessed every 5 minutes during the procedure

Secondary

MeasureTime frameDescription
Post anesthetic complications1 dayDuring stay at the post anesthetic care unit. Any new neurological symptoms etc

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026